drugset / Trial / NCT03095404

Intravenous Lidocaine for Post-Operative Pain Control in Patients Undergoing Bariatric Bowel Surgery

NCT03095404

RandomizedSingle-groupQuadruple-blindSupportive care

Summary

Currently, there are no studies that address the optimum dosage of lidocaine for surgical procedures. Lidocaine is a local anesthetic that is injected to induce anesthesia. Improper or inefficient pain treatment can lead to longer hospital stay, and adverse side effects such as nausea and vomiting. Opioids are the primary drug to treat moderate to severe pain, but are also responsible for nausea and other side effects. Lidocaine has shown to have opioid sparing effects; meaning less opioid use is necessary for pain relief. In this study, we will conduct a clinical trial to assess the difference between different lidocaine dosage schedules to determine the optimum dosage that brings maximum pain relief while minimizing adverse side effects and patient stay. A large benefit in using lidocaine is its documented opioid sparing which allows for minimal drug treatment.

Timeline

Start
2022-10-05
Primary completion
2025-08-26
Completion
2025-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1 % Intravenous
Subject Lidocaine Other / unclassified 2 % Intravenous

Indications

No indication recorded.